Director Wright Thomas Rowe purchases 1,030 shares of JHS at $10.90; stock now trading -4.2% over 30 days.
Director Wright Thomas Rowe initiated a position in John Hancock Income Securities Trust with a purchase of 1,030 shares at $10.90, adding a $11,227.00 commitment. The current price of $10.81 reflects a -4.2% decline over the past 30 days, suggesting market weakness since the transaction. This buy represents a first position for the insider (0 shares pre-transaction), and his cross-ticker track record shows 8 prior open-market buys, indicating a pattern of opportunistic purchasing behavior. The stock's position near the 52-week low of $10.72 and its -8.4% discount from the 52-week high place this transaction in a context of relative depressed valuations, though the modest transaction size and recent price momentum warrant standard observation.
Director Wright Thomas Rowe buys 726 shares of HPI at $15.16 (first purchase, 7 prior buys on other tickers).
Wright Thomas Rowe, a director, purchased 726 shares of JOHN HANCOCK PREFERRED INCOME FUND (HPI) at $15.16, establishing a new position in this security. This represents his first recorded transaction in HPI itself, though his cross-ticker track record shows 7 prior open-market buys across other securities. The purchase price of $15.16 sits near the 52-week low of $15.00 and well below the 52-week high of $19.30 (a -19.1% discount from the high), while the stock is currently down 6.1% over 30 days and 6.5% over 90 days. The absence of any prior holdings in HPI suggests this is a new entry, not an addition to an existing position.
Wright Thomas Rowe buys 715 shares of HPF at $15.39; first HPF position, 7 prior cross-ticker buys on record
Director Wright Thomas Rowe initiated a position in JOHN HANCOCK PREFERRED INCOME FUND II by purchasing 715 shares at $15.39, establishing his first holding of the security. The transaction occurred after the fund declined 4.2% over 30 days and sits 16.5% below its 52-week high of $18.98, suggesting the purchase coincided with a period of weakness. His cross-ticker purchase history shows 7 prior open-market buys, establishing a pattern of accumulation activity, though the new HPF position cannot be contextualized against his same-ticker record—this is his inaugural trade in this security.
Director Wright Thomas Rowe purchases 794 shares of HPS at $13.79; first position, stock down 3.8% in 30 days.
Wright Thomas Rowe initiated a position in John Hancock Preferred Income Fund III (HPS) by purchasing 794 shares at $13.79 on 2025-04-08, totaling $10,947.12. This represents the director's first-ever holding in this fund (0 shares pre-transaction). The purchase occurred while HPS has declined 3.8% over the prior 30 days and 4.4% over 90 days, trading at $14.28 currently, which is 17.2% below the 52-week high of $17.24. The director's cross-ticker open-market history shows 7 prior buys across other securities, providing a baseline pattern of acquisition activity, though this is the first measurable transaction in HPS for this insider.
Director Wright Thomas Rowe purchases 518 shares of HTD at $21.30 for $11,033.40; builds initial position from zero.
Wright Thomas Rowe, a Director, acquired 518 shares of John Hancock Tax-Advantaged Dividend Income Fund at $21.30, establishing a position where none previously existed. The transaction represents a modest $11,033.40 investment in a closed-end fund trading near the lower end of its 52-week range ($18.49–$24.04), roughly 9.9% below the year's peak. The purchase price of $21.30 sits above the current market price of $21.65, which has declined 6.0% over the prior 30 days. Across all open-market activity, the insider has demonstrated 7 prior buy transactions, indicating a pattern of purchasing activity in public markets.
Director Wright Thomas Rowe bought 1,139 shares of HEQ at $9.70 on 2025-04-08, establishing initial position.
Wright Thomas Rowe, a Director, initiated a position in John Hancock Diversified Income Fund by purchasing 1,139 shares at $9.70, with the position now valued at the current price of $10.09. The purchase occurred at a price near the 52-week low range ($9.45–$11.11) and roughly 9.2% below the 52-week high. This represents a first purchase by this insider, with a track record of 7 prior buys across other securities. The transaction volume and position size are modest relative to typical institutional holdings, and the fund remains in a slight downtrend over both 30-day (-2.9%) and 90-day (-2.1%) periods.
Director Wright Thomas Rowe buys 929 shares of PDT at $11.85; first position in fund
Wright Thomas Rowe purchased 929 shares of John Hancock Premium Dividend Fund at $11.85 on 2025-04-08, establishing an initial position totaling $11,006.33. The purchase price sits 3.6% below the current price of $12.29 and near the midpoint of the 52-week range of $10.73–$13.54. This is a routine initial investment in a dividend-focused closed-end fund by a director with 7 prior open-market purchases across other holdings. The transaction reflects discretionary capital allocation but lacks distinctive timing or scale characteristics relative to the fund's recent price action and the insider's broader trading history.
Director Wright Thomas Rowe bought 875 JHI shares at $12.57; stock down -11.6% from 52-week high
Wright Thomas Rowe, a director, purchased 875 shares of John Hancock Investors Trust at $12.57 on 2025-04-08, establishing an initial holding of 875 shares. The purchase occurred as the stock trades at $12.77, approximately -11.6% below its 52-week high of $14.45 and following a -7.2% decline over the prior 30 days. This marks the director's first transaction at this ticker, though his cross-ticker track record shows 7 prior buy transactions across other securities. The transaction is a modest absolute purchase and does not constitute a sufficiently large position or meaningful portfolio change to draw broad conclusions about directional conviction at this company.
Director Wright Thomas Rowe bought 378 BTO shares at $29.55; stock down 21.9% from 52-week high of $39.45
Director Wright Thomas Rowe purchased 378 shares of John Hancock Financial Opportunities Fund (BTO) at $29.55 on 2025-04-08, establishing an initial position in the closed-end fund. The purchase price sits below the 52-week high of $39.45 and the current price of $30.82. The transaction value of $11,169.14 represents a modest absolute commitment, and this marks one of 7 prior open-market buys in the director's cross-ticker transaction history. The fund has declined 5.2% over 30 days and 11.8% over 90 days, placing the purchase in a period of recent weakness.
